Search

Your search keyword '"post-infectious irritable bowel syndrome"' showing total 37 results

Search Constraints

Start Over You searched for: Descriptor "post-infectious irritable bowel syndrome" Remove constraint Descriptor: "post-infectious irritable bowel syndrome" Database MEDLINE Remove constraint Database: MEDLINE
37 results on '"post-infectious irritable bowel syndrome"'

Search Results

1. Gastrointestinal pathophysiology in long COVID: Exploring roles of microbiota dysbiosis and serotonin dysregulation in post-infectious bowel symptoms.

2. Impact of mechanical barrier damage and interleukin-17 on symptoms in patients with post-infectious irritable bowel syndrome.

3. Mechanisms of Electroacupuncture in Alleviating Visceral Hypersensitivity in Post-Infectious Irritable Bowel Syndrome Mice: The Role of GDNF Signaling Pathway and Gut Microbiota.

5. [Irritable bowel syndrome phenotypes: leading factors of genetics and epigenetics, mechanisms of formation].

6. Adenosine 2A receptor contributes to the facilitation of post-infectious irritable bowel syndrome by γδ T cells via the PKA/CREB/NF-κB signaling pathway.

7. Intestinal Barrier in Post- Campylobacter jejuni Irritable Bowel Syndrome.

8. Coptisine attenuates post‑infectious IBS via Nrf2‑dependent inhibition of the NLPR3 inflammasome.

9. Fecal microbiota transplantation in patients with post-infectious irritable bowel syndrome: A randomized, clinical trial.

10. Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT.

11. Upregulated adenosine 2A receptor accelerates post-infectious irritable bowel syndrome by promoting CD4+ T cells' T helper 17 polarization.

12. Increased prescriptions for irritable bowel syndrome after the 2018 Japan Floods: a longitudinal analysis based on the Japanese National Database of Health Insurance Claims and Specific Health Checkups.

13. [The effectiveness of a probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 in the treatment of post-infectious irritable bowel syndrome. Prospective randomized comparative study].

14. Campylobacter infection and the link with Irritable Bowel Syndrome: on the pathway towards a causal association.

15. Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats.

16. Increased Vδ1γδT cells predominantly contributed to IL-17 production in the development of adult human post-infectious irritable bowel syndrome.

17. Post-infectious irritable bowel syndrome after a laboratory-proven enteritis.

18. Pathogenesis and post-infectious complications in giardiasis.

19. Decreased expression of microRNA-510 in intestinal tissue contributes to post-infectious irritable bowel syndrome via targeting PRDX1.

20. Comparative transcriptional analysis for Toll-like receptors, inflammatory cytokines, and apoptotic genes in response to different cytolethal-encoding and noncoding isolates of Salmonella enterica and Campylobacter jejuni from food and human stool.

21. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.

22. Montezuma's revenge - the sequel: The one-hundred year anniversary of the first description of "post-infectious" irritable bowel syndrome.

23. [Electroacupuncture of "Tianshu" (ST 25) Suppresses Visceral Pain Possibly by Down-regulating Mast Cell Activation, and Tryptase and SP Expression in Rats with Post-infectious Irritable Bowel Syndrome].

24. Heat shock protein 70 protects mouse against post-infection irritable bowel syndrome via up-regulating intestinal γδ T cell's Th17 response.

25. Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum?

26. A Novel EphA2 Inhibitor Exerts Beneficial Effects in PI-IBS in Vivo and in Vitro Models via Nrf2 and NF-κB Signaling Pathways.

27. Review: chronic and persistent diarrhea with a focus in the returning traveler.

28. Giardia duodenalis induces pathogenic dysbiosis of human intestinal microbiota biofilms.

29. Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome.

30. Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis.

31. Giardiasis and Subsequent Irritable Bowel Syndrome: A Longitudinal Cohort Study Using Health Insurance Data.

32. Preinduced intestinal HSP70 improves visceral hypersensitivity and abnormal intestinal motility in PI-IBS mouse model.

34. Bacterial infections in childhood: A risk factor for gastrointestinal and other diseases?

35. Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection.

36. Extra-intestinal and long term consequences of Giardia duodenalis infections.

37. Trimebutine as a potential antimicrobial agent: a preliminary in vitro approach.

Catalog

Books, media, physical & digital resources